Toragen, Inc. Announces Appointment of Dr. Sandra Coufal, M.D. as CEO
Toragen is focused on uniquely selective drugs targeting cancers caused by the human papillomavirus (“HPV”)SAN DIEGO--(BUSINESS WIRE)--Toragen Inc., a San Diego-based biotechnology company focused on developing, repurposing and commercializing uniquely selective drugs targeting cancers caused by the human papillomav...
Source: pharmiweb.com